Clinical Trial Update: Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) [Phase 1]

View source ↗

Summary

Phase 1 trial updates report three combination arms: pazopanib with paclitaxel, pazopanib with paclitaxel plus carboplatin, and pazopanib with paclitaxel plus l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Taxol (paclitaxel)
• Tykerb (lapatinib)
• Votrient (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED